Ben Ponvilawan, MD, MS

@BPonvilawan

Heme/Onc Fellow @NorthwesternMed |@umkcIM alum, @CCLRI research fellow alum | Thoracic/GI Onc | 🇹🇭/🏳️‍🌈 | Tweets=my own

Chicago, IL

Joined February 2020

726Following

343Followers

Ben Ponvilawan, MD, MS Retweeted

H.O.M.E@hemeoncfellow · Jun 2

#ASCO2025

1.0K

Ben Ponvilawan, MD, MS Retweeted

Marc Roth@MarcRothMD · May 31

#ASCO25 Day 2: so proud of our two stellar residents, soon to be fellows! @Meddoc77 (Himil Mahadevia) and Parth Sharma. Congrats on the posters, can’t wait to see what your futures hold! @SLCI_KC @saintlukeskc

751

Ben Ponvilawan, MD, MS@BPonvilawan · May 30

🤩Honored to be a co-author on this important work led by our incredible attending Dr. Arya @royaryam, spotlighting the academic productivity of IMG fellows. Grateful for the opportunity to contribute!🙌 📅 Oral Presentation: 6/2/2025 | 9:45–9:51 AM 🔗 meetings.asco.org/abstracts-pres……

AArya Roy@royaryam · May 30

Excited to present our research on academic productivity of IMG fellows as an oral presentation at #ASCO25. Grateful for the opportunity to spotlight IMG contributions! @IMG_Oncologists @DrChoueiri @NazliDizman @ZiadBakouny @KarunNeupaneMD @ArdeshirFatemeh @OhioStateMedOnc

3.0K

Ben Ponvilawan, MD, MS Retweeted

IMG Oncologists@IMG_Oncologists · May 18

🚨Save the date🚨 @ASCO #IMG Community of Practice Meeting at #ASCO25 ⏰May 30st, 4-6 PM CST 📌Room S103, McCormick Place Join us to discuss barriers & opportunities for IMGs ASCO IMG CoP👉bit.ly/3JmJQwK @ASCOPost #IMGoncCoP #MedEd #MedTwitter

100

33.0K

Ben Ponvilawan, MD, MS Retweeted

Ivy Riano, M.D.@IvyLorena_Md · Apr 4

We encourage you to check out our article on tips for finding a HemeOnc job in the U.S. while on a J1 visa. It offers practical advice from individuals who have navigated the same process! @ASCO #ASCOConnections @RohitBanwar

10.0K

Ben Ponvilawan, MD, MS Retweeted

Chalothorn “Sai” Wannaphut, MD@Sai_Wannaphut · Mar 29

🎤 Excited to present at the #NCCN2025 Conference! @NCCN 📊 Racial Disparities in NSCLC Survival Outcomes: A Systematic Review & Meta-Analysis ✅ Asian/API patients had significantly better OS vs. White patients ❌ No significant differences in OS for Black or Hispanic patients…

2.0K

Ben Ponvilawan, MD, MS Retweeted

Dhruv Bansal MD, MBA@lungmedonc · Feb 17

Our paper recently published in @JAMANetworkOpen Doublet IO might be more beneficial in patients with pd-l1 negative squamous cell lung cancer jamanetwork.com/journals/jaman…

222

Ben Ponvilawan, MD, MS Retweeted

UMKC Internal Medicine Residency Program@umkcIM · Dec 6

Excited to celebrate the outstanding fellowship match results of our UMKC Internal Medicine residents! We’re proud of your achievements and look forward to your continued success in the next chapter of your careers. #UMKCIM #FellowshipMatch2024

10.0K

Ben Ponvilawan, MD, MS@BPonvilawan · Dec 5

Deeply honored to become a Heme/Onc fellow at @NorthwesternMed starting next July! Super grateful to my family, friends, mentors, @umkcIM, and everyone who has supported me throughout the long journey. @NUHemOncFellow @hemeoncfellow #Match2025 #HemeOnc

BPonvilawan's tweet image. Deeply honored to become a Heme/Onc fellow at @NorthwesternMed starting next July!

Super grateful to my family, friends, mentors, @umkcIM, and everyone who has supported me throughout the long journey.

@NUHemOncFellow @hemeoncfellow #Match2025 #HemeOnc

162

7.0K

Ben Ponvilawan, MD, MS@BPonvilawan · Oct 11

Our correspondence is now available on @TheLancet! Differences in HCC etiology may contribute to the positive result of camrelizumab plus rivoceranib in CARES-310 trial, in contrast to other IO+TKI trials. Thank you @MarcRothMD @SLCI_KC for the support. thelancet.com/journals/lance…

1.0K

Ben Ponvilawan, MD, MS Retweeted

Rami Manochakian MD, FASCO Cancer Education@RManochakian · Oct 7

🔥🚨1/2 Hot off the press. Just published @JCOOP_ASCO #Guide to Understanding & Supporting #International #MedicalGraduates in #Hematology/#Oncology by @ASCO #IMGs Community of Practice. I’m honored to be part of this work with GREAT COLLEAGUES. 👇🏼 tinyurl.com/2su6r8zx

7.0K

Ben Ponvilawan, MD, MS@BPonvilawan · Sep 20

This is a nice summary of the mechanisms of action of various KRAS inhibitors from Adrienne Cox & @cjder23 in their @ScienceMagazine perspective.

AAnirban Maitra@Aiims1742 · Sep 20

The @Boehringer KRAS degrader in @ScienceMagazine science.org/doi/10.1126/sc… Perspective from Adrienne Cox & @cjder23 science.org/doi/10.1126/sc…

251

150

73.0K

Ben Ponvilawan, MD, MS Retweeted

Matt Yurgelun, MD@MattYurgelun · Sep 11

New ⁦@NCCN⁩ guidelines for Breast/Ovarian/Pancreatic Cancer Genetics posted at nccn.org/professionals/… New recommendation that #PancreaticCancer screening be “considered” for all BRCA2 and ATM pathogenic variant carriers by age 50, even without known family history

165

22.0K

Ben Ponvilawan, MD, MS@BPonvilawan · Sep 10

Happy to present a mini oral presentation about identifying patient population that may benefit more from double ICI regimen compared to those with single ICI. Thank you for the gracious support and mentorship from @dhruvsxu @RamSubraMD #WCLC24 @hemeoncfellow @IASLC

BPonvilawan's tweet image. Happy to present a mini oral presentation about identifying patient population that may benefit more from double ICI regimen compared to those with single ICI. Thank you for the gracious support and mentorship from @dhruvsxu @RamSubraMD

#WCLC24 @hemeoncfellow @IASLC

2.0K

Ben Ponvilawan, MD, MS Retweeted

H.O.M.E@hemeoncfellow · Sep 10

Successful Hemeonc #Match2025 fellowship applicants meet up led by @drtulsijose at the #WCLC24 conference, San Diego. Future of #hemeonc is bright with PDs like @RManochakian advocating for Diversity, Equity & Inclusivity. @vyasabhinav2 @sawyer_bawek @SakditadMD @BPonvilawan

1.0K

Ben Ponvilawan, MD, MS Retweeted

Sakditad “Tew” Saowapa, MD@SakditadMD · Sep 8

Proudly presenting my e-poster research at #WCLC24 Excited to share insights and contribute to the conversation! EP.11A.29 C-Reactive Protein's Impact on Immune Adverse Events in Non Small Cell Lung Cancer Patients Undergoing Immunotherapy: Meta-Analysis @IASLC @hemeoncfellow

938

Ben Ponvilawan, MD, MS Retweeted

Sakditad “Tew” Saowapa, MD@SakditadMD · Sep 8

🥳 Congratulations! @KanishkaUttam for 2 posters here! And @BPonvilawan for mini oral presentation Such a strong work! We will do great in matching this year! 🩺🪬 @hemeoncfellow @HemOncFellows @IASLC #WCLC24

535

Ben Ponvilawan, MD, MS Retweeted

Patrick Forde@FordePatrick · Sep 8

With the goal of addressing a key clinical question, which pts w lung cancer may benefit from adjuvant immunotherapy after neoadjuvant, today at #WCLC2024 we presented results of an exploratory individual pt level analysis of the #CM77T & #CM816 trials 1/

202

42.0K

Ben Ponvilawan, MD, MS Retweeted

Rami Manochakian MD, FASCO Cancer Education@RManochakian · Sep 8

🔥🚨@OncoAlert HOT OFF THE PRESS. Just presented at the presidential symposium @IASLC #WCLC24 Results of #HARMONi2 trial of #Ivonescimab VS #Pembrolizumab in advanced non-small cell #LungCancer with PD-L1 >1%. ✅ Significant ⬆️mPFS 11.14 vs. 5.82 months (HR 0.51) #Benefit…

101

10.0K

Ben Ponvilawan, MD, MS Retweeted

Sakditad “Tew” Saowapa, MD@SakditadMD · Sep 7

Interesting session! with this super smart guy @BPonvilawan live now at 33ABC San Diego Convention Center! Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC 🧬🩻💉 Best wish for our #hemonc #match2025 @IASLC #WCLC24

740